Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Niurys de-Castro"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gledys Reynaldo Fernández, Eduardo M. Fernández-Sánchez, Mayra Ramos Suzarte, Daniel Amaro, Roberto Menéndez, Helena Colom, Víctor Mangas-Sanjuan, Gilberto Castañeda, Jorge Duconge, Braulio Jiménez-Vélez, Niurys de Castro Suárez, Carmen Viada, Joaquín Solazábal, María de los A. Bécquer
Publikováno v:
Anales de la Academia de Ciencias de Cuba, Vol 10, Iss 3 (2020)
Introducción. La farmacometría es una disciplina científica vibrante que está conformada por el ciclo de excelencia: integración, innovación e impacto. Objetivo: Evaluar diferentes enfoques farmacométricos en tres productos biotecnológicos cu
Externí odkaz:
https://doaj.org/article/2596f3b4e5dc4692a1fa199da1097f0c
Autor:
Niurys de Castro-Suárez, Mirjam N. Trame, Mayra Ramos-Suzarte, José M. Dávalos, Raymed A. Bacallao-Mendez, Anaelys R. Maceo-Sinabele, Víctor Mangas-Sanjuán, Gledys Reynaldo-Fernández, Leyanis Rodríguez-Vera
Publikováno v:
Pharmaceutics, Vol 12, Iss 12, p 1147 (2020)
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this st
Externí odkaz:
https://doaj.org/article/972aabe181b8495eac84e5c33068ba8d
Publikováno v:
CPT Pharmacometrics Syst Pharmacol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e657d8f552256cdaedfbbdf303b1f2b1
https://doi.org/10.1002/psp4.12497
https://doi.org/10.1002/psp4.12497
Autor:
Mirjam N. Trame, Leyanis Rodríguez-Vera, Raymed A. Bacallao-Méndez, Niurys de Castro-Suárez, Anaelys R. Maceo-Sinabele, Victor Mangas-Sanjuan, Mayra Ramos-Suzarte, Jose M. Davalos, Gledys Reynaldo-Fernández
Publikováno v:
Pharmaceutics, Vol 12, Iss 1147, p 1147 (2020)
Pharmaceutics
Volume 12
Issue 12
Pharmaceutics
Volume 12
Issue 12
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4a4b4d4fa0cc75d2fff9202b17e228
https://www.mdpi.com/1999-4923/12/12/1147
https://www.mdpi.com/1999-4923/12/12/1147
Autor:
Leyanis Rodriguez Vera, Niurys de Castro Suárez, Jorge Luis Soriano, Mayra Ramoz Suzarte, Eduardo Fernández Sánchez, Gilberto Castañeda, Helena Colom Codina
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c43a6220f1601f63f41268ad7b6380bc
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-8-42
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-8-42
Autor:
Mayra Ramos Suzarte, Carlos Villegas, Raymed Bacallao, Niurys de Castro-Suárez, Patricia Lorenzo Luaces, Leyanis Rodriguez Vera, Jose M. Davalos
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5606f2bfb447666fddf2cc8171f33135
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-11-8
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-11-8
Autor:
José M. Dávalos-Iglesias, Carlos Villegas, Christian Leyva-de la Torre, Raymed A. Bacallao-Méndez, Mayelin Troche-Concepción, Betsy Llerena-Ferrer, Niurys de Castro-Suárez, Patricia Lorenzo Luaces, Mayra Ramos-Suzarte, Leyanis Rodríguez-Vera
Publikováno v:
Journal of clinical pharmacology. 59(6)
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression and mislocalization of epidermal growth factor receptor (EGFR) to the apical membranes of cystic epithelial cells. Nimotuzumab is a humanized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0a7d80c83809c4599a80b2398efc22
https://pubmed.ncbi.nlm.nih.gov/30633365
https://pubmed.ncbi.nlm.nih.gov/30633365
Autor:
Leyanis Rodríguez-Vera, Carlos Orlando Jacobo‐Cabral, Helena Colom Codina, Concepción Peraire Guitart, Niurys de Castro Suárez, Mayra Ramos-Suzarte, Eduardo Fernández-Sánchez, Jorge Luis Soriano, Gilberto Castañeda Hernández
Publikováno v:
Journal of clinical pharmacology. 55(8)
This study aimed (1) to develop a semimechanistic pharmacokinetic (PK) model for nimotuzumab in patients with advanced breast cancer and (2) to identify demographic, biochemical, and clinical predictive factors of the PK variability. Data from a phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2655d32d728594007825ae0b2388f5
https://pubmed.ncbi.nlm.nih.gov/25760761
https://pubmed.ncbi.nlm.nih.gov/25760761
Autor:
Jose Vaquer, Rafael Domíngez, Martha Gonzalez Griego, Mauricio Catala, Tania Crombet, Javier Ballesteros, Nelson Quintanal, Jorge Juan Marinello, Patricia Lorenzo Luaces, Maria Teresa Solomon, Silvia Salva, Ferdinand Bach, Javier Figueredo, Julio Cesar Selva, Jose Alert, Juan Antonio Martell, Niurys de-Castro, Carolina Toledo
Publikováno v:
Addi. Archivo Digital para la Docencia y la Investigación
instname
BMC Cancer
instname
BMC Cancer
Background The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth Factor Receptor (EGFR) is well validated as a primary contributor of glioma initiation and progression. Nimotuzumab is a humanized monoclonal antibody tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baddac458451659a46a9a9152177be4c